Aclaris Therapeutics, Inc. (ACRS)

Number of records: 50
SEC FilingInsiderCompanyTrade DateTransactionSharesAvg. PriceTotal% HoldingsReturn
05-Mar-24 4:58 PM
View: 
Powell Andrew Kenneth William
Director
Aclaris Therapeutics, Inc. (ACRS) 04-Mar-24Purchase 6,000$1.25$7,500.0026%
22.86K to 28.86K
05-Mar-24 5:04 PM
View: 
Monahan Joseph
Chief Scientific Officer
Aclaris Therapeutics, Inc. (ACRS) 02-Mar-24Option Exercise 12,500----7%
178.01K to 190.51K
05-Mar-24 5:02 PM
View: 
Balthaser Kevin
Chief Financial Officer
Aclaris Therapeutics, Inc. (ACRS) 02-Mar-24Payment of Exercise 427$1.24$529.48(2%)
24.41K to 23.98K
05-Mar-24 5:04 PM
View: 
Monahan Joseph
Chief Scientific Officer
Aclaris Therapeutics, Inc. (ACRS) 02-Mar-24Payment of Exercise 3,531$1.24$4,378.44(2%)
190.51K to 186.98K
05-Mar-24 5:02 PM
View: 
Balthaser Kevin
Chief Financial Officer
Aclaris Therapeutics, Inc. (ACRS) 02-Mar-24Option Exercise 1,500----7%
22.91K to 24.41K
05-Mar-24 5:04 PM
View: 
Monahan Joseph
Chief Scientific Officer
Aclaris Therapeutics, Inc. (ACRS) 01-Mar-24Payment of Exercise 17,752$1.24$22,012.50(9%)
195.76K to 178.01K
05-Mar-24 5:08 PM
View: 
Walker Neal
Interim President and CEO
Director
Aclaris Therapeutics, Inc. (ACRS) 01-Mar-24Payment of Exercise 3,223$1.24$3,996.52(< 1%)
1.28M to 1.28M
05-Mar-24 4:58 PM
View: 
Powell Andrew Kenneth William
Director
Aclaris Therapeutics, Inc. (ACRS) 01-Mar-24Private Purchase 8,500$1.23$10,455.0059%
14.36K to 22.86K
05-Mar-24 5:08 PM
View: 
Walker Neal
Interim President and CEO
Director
Aclaris Therapeutics, Inc. (ACRS) 01-Mar-24Option Exercise 9,466----< 1%
1.27M to 1.28M
05-Mar-24 5:02 PM
View: 
Balthaser Kevin
Chief Financial Officer
Aclaris Therapeutics, Inc. (ACRS) 01-Mar-24Option Exercise 3,475----17%
20.43K to 23.9K
05-Mar-24 5:04 PM
View: 
Monahan Joseph
Chief Scientific Officer
Aclaris Therapeutics, Inc. (ACRS) 01-Mar-24Option Exercise 60,925----45%
134.83K to 195.76K
05-Mar-24 5:02 PM
View: 
Balthaser Kevin
Chief Financial Officer
Aclaris Therapeutics, Inc. (ACRS) 01-Mar-24Payment of Exercise 990$1.24$1,227.60(4%)
23.9K to 22.91K
05-Feb-24 7:31 PM
View: 
Monahan Joseph
Chief Scientific Officer
Aclaris Therapeutics, Inc. (ACRS) 01-Feb-24Payment of Exercise 2,583$1.20$3,099.60(2%)
137.42K to 134.83K
05-Feb-24 7:29 PM
View: 
Loerop James
Chief Business Officer
Aclaris Therapeutics, Inc. (ACRS) 01-Feb-24Payment of Exercise 6,421$1.20$7,705.20(16%)
40.44K to 34.02K
05-Feb-24 7:31 PM
View: 
Monahan Joseph
Chief Scientific Officer
Aclaris Therapeutics, Inc. (ACRS) 01-Feb-24Option Exercise 7,500----6%
129.92K to 137.42K
05-Feb-24 7:29 PM
View: 
Loerop James
Chief Business Officer
Aclaris Therapeutics, Inc. (ACRS) 01-Feb-24Option Exercise 18,750----86%
21.69K to 40.44K
03-Jan-24 4:47 PM
View: 
Balthaser Kevin
Chief Financial Officer
Aclaris Therapeutics, Inc. (ACRS) 01-Jan-24Payment of Exercise 2,536$1.05$2,662.80(11%)
22.96K to 20.43K
03-Jan-24 4:44 PM
View: 
Manion Douglas J.
Pres and CEO
Director
Aclaris Therapeutics, Inc. (ACRS) 01-Jan-24Payment of Exercise 9,125$1.05$9,581.25(18%)
50.94K to 41.81K
03-Jan-24 4:47 PM
View: 
Balthaser Kevin
Chief Financial Officer
Aclaris Therapeutics, Inc. (ACRS) 01-Jan-24Option Exercise 7,500----49%
15.46K to 22.96K
03-Jan-24 4:44 PM
View: 
Manion Douglas J.
Pres and CEO
Director
Aclaris Therapeutics, Inc. (ACRS) 01-Jan-24Option Exercise 27,000----113%
23.94K to 50.94K
25-Oct-23 4:28 PM
View: 
Monahan Joseph
Chief Scientific Officer
Aclaris Therapeutics, Inc. (ACRS) 23-Oct-23Sale (Planned) 6,000$5.08$30,460.20(4%)
135.92K to 129.92K
07-Sep-23 4:16 PM
View: 
Balthaser Kevin
Chief Financial Officer
Aclaris Therapeutics, Inc. (ACRS) 06-Sep-23Private Purchase 9,490$7.90$74,971.00159%
5.97K to 15.46K
05-Sep-23 5:08 PM
View: 
Balthaser Kevin
Chief Financial Officer
Aclaris Therapeutics, Inc. (ACRS) 01-Sep-23Payment of Exercise 285$7.90$2,251.50(5%)
6.26K to 5.97K
05-Sep-23 5:08 PM
View: 
Balthaser Kevin
Chief Financial Officer
Aclaris Therapeutics, Inc. (ACRS) 01-Sep-23Option Exercise 1,000----19%
5.26K to 6.26K
28-Aug-23 4:39 PM
View: 
Loerop James
Chief Business Officer
Aclaris Therapeutics, Inc. (ACRS) 28-Aug-23Private Purchase 14,705$6.80$99,958.70211%
6.98K to 21.69K
22-Aug-23 4:31 PM
View: 
Monahan Joseph
Chief Scientific Officer
Aclaris Therapeutics, Inc. (ACRS) 21-Aug-23Sale (Planned) 6,000$7.32$43,894.80(4%)
141.92K to 135.92K
03-Aug-23 4:24 PM
View: 
Manion Douglas J.
Pres and CEO
Director
Aclaris Therapeutics, Inc. (ACRS) 01-Aug-23Option Exercise 15,575----122%
12.8K to 28.38K
03-Aug-23 4:24 PM
View: 
Manion Douglas J.
Pres and CEO
Director
Aclaris Therapeutics, Inc. (ACRS) 01-Aug-23Payment of Exercise 4,437$9.81$43,527.00(16%)
28.38K to 23.94K
05-Jul-23 4:23 PM
View: 
Cawkwell Gail
Chief Medical Officer
Aclaris Therapeutics, Inc. (ACRS) 01-Jul-23Payment of Exercise 5,407$10.37$56,070.60(36%)
15.0K to 9.59K
05-Jul-23 4:23 PM
View: 
Cawkwell Gail
Chief Medical Officer
Aclaris Therapeutics, Inc. (ACRS) 01-Jul-23Option Exercise 15,000----100%
0 to 15.0K
22-Jun-23 4:32 PM
View: 
Molineaux Christopher P.
Director
Aclaris Therapeutics, Inc. (ACRS) 20-Jun-23Option Exercise 16,500$1.41$23,265.0052%
32.0K to 48.5K
22-Jun-23 4:30 PM
View: 
Monahan Joseph
Chief Scientific Officer
Aclaris Therapeutics, Inc. (ACRS) 20-Jun-23Sale (Planned) 6,000$10.28$61,662.60(4%)
147.92K to 141.92K
20-Jun-23 4:31 PM
View: 
Molineaux Christopher P.
Director
Aclaris Therapeutics, Inc. (ACRS) 15-Jun-23Option Exercise 249$1.36$337.68< 1%
31.75K to 32.0K
05-Jun-23 4:50 PM
View: 
Powell Andrew Kenneth William
Director
Aclaris Therapeutics, Inc. (ACRS) 02-Jun-23Option Exercise 4,507----46%
9.86K to 14.36K
05-Jun-23 4:45 PM
View: 
Mehra Anand
Director
Aclaris Therapeutics, Inc. (ACRS) 02-Jun-23Option Exercise 4,507----13%
34.2K to 38.7K
05-Jun-23 5:08 PM
View: 
Milano Vincent
Director
Aclaris Therapeutics, Inc. (ACRS) 02-Jun-23Option Exercise 4,507----134%
3.36K to 7.86K
05-Jun-23 5:02 PM
View: 
Molineaux Christopher P.
Director
Aclaris Therapeutics, Inc. (ACRS) 02-Jun-23Option Exercise 4,507----17%
27.25K to 31.75K
05-Jun-23 4:57 PM
View: 
Reasons Bryan M.
Director
Aclaris Therapeutics, Inc. (ACRS) 02-Jun-23Option Exercise 4,507----23%
19.57K to 24.07K
05-Jun-23 5:12 PM
View: 
Humphries William D.
Director
Aclaris Therapeutics, Inc. (ACRS) 02-Jun-23Option Exercise 4,507----23%
19.57K to 24.07K
05-Jun-23 4:53 PM
View: 
Schiff Dr Drew
Director
Aclaris Therapeutics, Inc. (ACRS) 02-Jun-23Option Exercise 4,507----1%
434.45K to 438.96K
05-Jun-23 5:04 PM
View: 
Gowen Maxine
Director
Aclaris Therapeutics, Inc. (ACRS) 02-Jun-23Option Exercise 4,507----58%
7.79K to 12.3K
17-Mar-23 5:03 PM
View: 
Manion Douglas J.
Pres and CEO
Director
Aclaris Therapeutics, Inc. (ACRS) 17-Mar-23Private Purchase 6,300$7.86$49,532.5097%
6.5K to 12.8K
09-Mar-23 5:56 PM
View: 
Manion Douglas J.
Pres and CEO
Director
Aclaris Therapeutics, Inc. (ACRS) 09-Mar-23Private Purchase 6,500$7.74$50,277.50100%
0 to 6.5K
03-Mar-23 10:00 PM
View: 
Monahan Joseph
Chief Scientific Officer
Aclaris Therapeutics, Inc. (ACRS) 03-Mar-23Option Sale 16,037$12.63$202,615.00(10%)
163.95K to 147.92K
03-Mar-23 10:00 PM
View: 
Walker Neal
Director
Aclaris Therapeutics, Inc. (ACRS) 03-Mar-23Option Sale 30,240$12.63$382,070.00(2%)
1.3M to 1.27M
03-Mar-23 10:00 PM
View: 
Balthaser Kevin
Chief Financial Officer
Aclaris Therapeutics, Inc. (ACRS) 03-Mar-23Option Sale 894$12.63$11,289.50(15%)
6.15K to 5.26K
03-Mar-23 10:00 PM
View: 
Balthaser Kevin
Chief Financial Officer
Aclaris Therapeutics, Inc. (ACRS) 02-Mar-23Option Exercise 1,500----27%
5.65K to 7.15K
03-Mar-23 10:00 PM
View: 
Walker Neal
Director
Aclaris Therapeutics, Inc. (ACRS) 02-Mar-23Option Sale 29,000$12.37$358,588.00(2%)
1.33M to 1.3M
03-Mar-23 10:00 PM
View: 
Balthaser Kevin
Chief Financial Officer
Aclaris Therapeutics, Inc. (ACRS) 02-Mar-23Option Sale 1,000$12.29$12,289.00(14%)
7.15K to 6.15K
03-Mar-23 10:00 PM
View: 
Monahan Joseph
Chief Scientific Officer
Aclaris Therapeutics, Inc. (ACRS) 02-Mar-23Option Sale 14,800$12.37$183,024.00(8%)
178.75K to 163.95K